Clinical Trial Update: Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis. [Phase 2]

View source ↗

Summary

The update notes the completion of a Phase 2 exploratory trial assessing dalfampridine (BIIB041) for walking ability and balance in people with multiple scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED